Company Name: Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals, Inc. is engaged in the development of antibacterial therapeutics using tetracycline chemistry. The company’s lead product candidate is a broad spectrum antibiotic designed as an empiric monotherapy for serious community acquired bacterial infections.
Ticker Symbol: PRTK (NASDAQ)
Company Website: www.paratekpharm.com
Headquarters: Boston, MA